Literature DB >> 1902619

Platelet dysfunction in Noonan's syndrome. A case with a platelet cyclooxygenase-like deficiency and chronic idiopathic thrombocytopenic purpura.

J T Flick1, A K Singh, J Kizer, J Lazarchick.   

Abstract

Individuals with Noonan's syndrome are likely to have one or more coagulation abnormalities: complex platelet function defects, partial Factor XI deficiency, or von Willebrand's disease. A distinctive platelet function defect has not been identified. The authors describe a 24-year-old women with Noonan's syndrome, chronic idiopathic thrombocytopenic purpura (ITP), and a platelet function defect characterized by a greater than 15-minute bleeding time, failure of aggregation and release with 10 microM ADP, 10 microM epinephrine, 750 microM arachidonic acid or 0.019 g/L collagen. A mixture of aspirin-treated platelets with the patient's platelets failed to correct the defect. Addition of 2.5 microM U46619 (a PGG2 analogue) corrected the aggregation and release defect. An electron microscopic analysis failed to reveal structural abnormalities. Thus, the platelet function defect in this patient appears to be a functional deficiency of cyclooxygenase. The presence of autoantiplatelet antibodies in a clinical setting consistent with chronic ITP raises the possibility that the defect may be acquired.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902619     DOI: 10.1093/ajcp/95.5.739

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Severe congenital thrombocytopaenia--first clinical manifestation of Noonan syndrome.

Authors:  Paula Nunes; Sara Aguilar; Sara Noéme Prado; Maria João Palaré; Anabela Ferrão; Anabela Morais
Journal:  BMJ Case Rep       Date:  2012-03-20

2.  8-BuS-ATP derivatives as specific NTPDase1 inhibitors.

Authors:  Joanna Lecka; Irina Gillerman; Michel Fausther; Mabrouka Salem; Mercedes N Munkonda; Jean-Philippe Brosseau; Christine Cadot; Mireia Martín-Satué; Pedro d'Orléans-Juste; Eric Rousseau; Donald Poirier; Beat Künzli; Bilha Fischer; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

3.  The Utility of Platelet and Coagulation Testing of Antithrombotics: Fusing Science with Patient Care.

Authors:  Lisa K Jennings; Jayaprakash Kotha
Journal:  Drug Dev Res       Date:  2013-11-15       Impact factor: 4.360

4.  DRESS syndrome with thrombotic microangiopathy revealing a Noonan syndrome: Case report.

Authors:  Mickaël Bobot; Matteo Coen; Clémentine Simon; Laurent Daniel; Gilbert Habib; Jacques Serratrice
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

5.  Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review.

Authors:  Diane J Nugent; Alicia A Romano; Shreya Sabharwal; David L Cooper
Journal:  J Blood Med       Date:  2018-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.